Skip to main content
. 2016 Apr 29;7(24):36049–36064. doi: 10.18632/oncotarget.9102

Figure 7. Expression of HoxA13 and IGFBP-3 in specimens of gastric cancer patients.

Figure 7

(A, B) Representative immunohistochemical staining shows strong (score > 4), weak (score < 2) and non (isotype control) expression of HoxA13 (A) and IGFBP-3 (B). (C) Schematic representation of the HoxA13–HOTTIP–IGFBP-3 axis during the development of gastric cancer. EMT: epithelial mesenchymal transition.